04/10/2024
3:24 PM | Jones Jullian G (Reporting)
Monte Rosa Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024
11:58 AM | Monte Rosa Therapeutics (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
| Form SC 13G/A | |
03/14/2024
6:44 AM | Monte Rosa Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/14/2024
6:05 AM | Monte Rosa Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
10:22 AM | BlackRock Inc. (Filed by)
Monte Rosa Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
8:14 AM | Avoro Capital Advisors LLC (Filed by)
Monte Rosa Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
8:28 AM | FMR LLC (Filed by)
Monte Rosa Therapeutics (Subject)
| Form SC 13G/A | |
|
01/08/2024
6:47 AM | Monte Rosa Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
3:15 PM | Monte Rosa Therapeutics (Issuer)
Nickson Philip (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:15 PM | Dunn Edmund (Reporting)
Monte Rosa Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:15 PM | Janku Filip (Reporting)
Monte Rosa Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:15 PM | Jones Jullian G (Reporting)
Monte Rosa Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:15 PM | Monte Rosa Therapeutics (Issuer)
Wallace Owen B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:15 PM | Monte Rosa Therapeutics (Issuer)
Warmuth Markus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2023
4:26 PM | Monte Rosa Therapeutics (Subject)
Versant Venture Capital VI, L.P. (Filed by)
| Form SC 13D/A | |
11/09/2023
6:27 AM | Monte Rosa Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/26/2023
4:01 PM | Monte Rosa Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/26/2023
3:55 PM | Monte Rosa Therapeutics (Filer)
| Form 424B5 | |
10/17/2023
6:55 AM | Monte Rosa Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2023
4:16 PM | Monte Rosa Therapeutics (Subject)
Tamboli Ajim (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/10/2023
6:30 AM | Monte Rosa Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/10/2023
6:19 AM | Monte Rosa Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/15/2023
3:42 PM | Behbahani Ali (Reporting)
Monte Rosa Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:26 PM | Blackwell Kimberly (Reporting)
Monte Rosa Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:27 PM | Mayweg Alexander (Reporting)
Monte Rosa Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:28 PM | Monte Rosa Therapeutics (Issuer)
SCHIFF ANDREW N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:28 PM | Monte Rosa Therapeutics (Issuer)
Siu Christine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:29 PM | Monte Rosa Therapeutics (Issuer)
Skvarka Jan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/11/2023
6:34 AM | Monte Rosa Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2023
3:02 PM | Monte Rosa Therapeutics (Filer)
| Form DEF 14A | |
